GÜLBAĞCI, B. B., ÖZEN, M., ENGİN, E. Ö., KAHVECİOĞLU, F. A., ÇİFTÇİ, E., & HACIBEKİROĞLU, İ. (2024). Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors? Tekirdağ Namık Kemal University.
Stile di citazione ChicagoGÜLBAĞCI, Burcu Belen, Miraç ÖZEN, Esra ÖZEN ENGİN, Fatma AKDAĞ KAHVECİOĞLU, Esra ÇİFTÇİ, e İlhan HACIBEKİROĞLU. Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated With CDK4/6 Inhibitors? Tekirdağ Namık Kemal University, 2024.
Citazione MLAGÜLBAĞCI, Burcu Belen, et al. Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated With CDK4/6 Inhibitors? Tekirdağ Namık Kemal University, 2024.